Review
Accepted on 30 Jun 2025
Mapping the Oxidative Landscape in Cystic Fibrosis: Methodological Frontiers and Application
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1632924
Type at least 3 characters
628 articles
Case Report
Accepted on 27 Jun 2025
Case Report: Coadministration of TNF-α Blockade as an Effective Adjunctive Strategy in the Treatment of ANCA-Negative EGPA with Refractory Peripheral Neuropathy
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1555377
- 102 views
Review
Published on 26 Jun 2025
Oxidative stress in ARDS: mechanisms and therapeutic potential
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1603287
- 330 views
Original Research
Published on 25 Jun 2025
Role and mechanism of IGFBP5 in the real-ambient particulate matter exposure-induced chronic lung injury
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1604301
- 257 views
Case Report
Published on 25 Jun 2025
Case Report: Polymyxin B-induced anaphylactic shock
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1594127
- 255 views
Editorial
Accepted on 19 Jun 2025
Editorial: Use of Bioactives for Treatment of Respiratory Diseases
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1630486
- 128 views
Original Research
Published on 19 Jun 2025
Drug-related problems in elderly patients with AECOPD and pharmaceutical intervention practice: a prospective study
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1596795
- 407 views
Original Research
Published on 18 Jun 2025
Oral Angiotensin-(1-7) formulation after established elastase-induced emphysema suppresses inflammation and restores lung architecture
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1540475
- 437 views
Original Research
Accepted on 16 Jun 2025
EPA-Lactone derivative, 5,6-diHETE lactone, improves pulmonary arterial hypertension in a monocrotaline-induced model
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1621030
- 150 views
Original Research
Accepted on 16 Jun 2025
Novel mitophagy inducer TJ0113 alleviates pulmonary inflammation during acute lung injury
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1590458
- 138 views
Original Research
Published on 13 Jun 2025
Clinical features and genetic spectrum of children with primary ciliary dyskinesia in central China: a referral center retrospective analysis
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1526675
- 484 views
Case Report
Accepted on 11 Jun 2025
Omalizumab Combined with Voriconazole for the Treatment of ABPA Complicating IPA: A Case Report
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1588182
- 208 views
Editorial
Published on 11 Jun 2025
Editorial: Applications of AI, machine learning, computational medicine, and bioinformatics in respiratory pharmacology
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1602941
- 911 views
Original Research
Published on 05 Jun 2025
Machine learning-based prediction model for lung ischemia-reperfusion injury: insights from disulfidptosis-related genes
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1545111
- 646 views
Original Research
Published on 05 Jun 2025
Real-world treatment persistence and predictive factors for discontinuation of antifibrotic therapies in patients with idiopathic pulmonary fibrosis: a post-hoc analysis of two multicenter observational cohort studies in Poland
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1586197
- 958 views
Original Research
Published on 30 May 2025
Efficacy and safety of a new drug formulation, amoxicillin-clavulanate-cineole, for adult lower respiratory tract infections: a nationwide observational study in Morocco
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1549014
- 719 views